Constellation Pharmaceuticals Announces First-Quarter 2020 Financial Results Portfolio News / By Karina Tin May 6, 2020 Constellation Pharmaceuticals Announces First-Quarter 2020 Financial Results Read More »
Arcus Biosciences Announces First Quarter 2020 Financial Results and Corporate Updates Portfolio News / By Karina Tin May 5, 2020 Arcus Biosciences Announces First Quarter 2020 Financial Results and Corporate Updates Read More »
ORIC Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Portfolio News / By Karina Tin April 28, 2020 ORIC Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Read More »
Ribon Therapeutics Presents Preclinical Data from its PARP7 and PARP14 Programs at AACR Virtual Meeting I Portfolio News / By Karina Tin April 27, 2020 Ribon Therapeutics Presents Preclinical Data from its PARP7 and PARP14 Programs at AACR Virtual Meeting I Read More »
Accent Therapeutics Announces $63 Million Series B Financing to Advance Novel, Precision Cancer Therapies Targeting RNA-Modifying Proteins Portfolio News / By Karina Tin April 23, 2020 Accent Therapeutics Announces $63 Million Series B Financing to Advance Novel, Precision Cancer Therapies Targeting RNA-Modifying Proteins Read More »
RAPT Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Business Update Portfolio News / By admin March 30, 2020 RAPT Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Business Update Read More »
Surrozen Announces Publication of Antibody Platform Technology in Cell Chemical Biology Portfolio News / By admin March 30, 2020 Surrozen Announces Publication of Antibody Platform Technology in Cell Chemical Biology Read More »
Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis Portfolio News / By admin March 25, 2020 Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis Read More »
NGM Bio Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights Portfolio News / By admin March 17, 2020 NGM Bio Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights Read More »
Circle Pharma raises $45 Million in Series B Financing Portfolio News / By admin March 17, 2020 Circle Pharma raises $45 Million in Series B Financing Read More »
